Found: 136
Select item for more details and to access through your institution.
Voriconazole-associated severe hyponatremia.
- Published in:
- Medical Mycology, 2012, v. 50, n. 1, p. 103, doi. 10.3109/13693786.2011.587210
- By:
- Publication type:
- Article
Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11038-6
- By:
- Publication type:
- Article
Comparative Pharmacokinetics Between a Fixed‐Dose Combination of Pitavastatin/Valsartan 4/160 mg and the Corresponding Individual Components Through a Partial Replicated Crossover Design in Healthy Male Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 5, p. 615, doi. 10.1002/cpdd.1054
- By:
- Publication type:
- Article
Pharmacokinetics of Ginsenoside Compound K From a Compound K Fermentation Product, CK‐30, and From Red Ginseng Extract in Healthy Korean Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 11, p. 1358, doi. 10.1002/cpdd.949
- By:
- Publication type:
- Article
Pharmacokinetics of a Fixed‐Dose Combination of Amlodipine/Losartan and Chlorthalidone Compared to Concurrent Administration of the Separate Components.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 1, p. 91, doi. 10.1002/cpdd.963
- By:
- Publication type:
- Article
Influence of CYP2C19 Polymorphisms on the Pharmacokinetics of Omeprazole in Elderly Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1469, doi. 10.1002/cpdd.966
- By:
- Publication type:
- Article
Comparison of the Pharmacokinetics of a Fixed‐Dose Combination of Rosuvastatin/Metformin Sustained‐Release (10/1000 mg) and Separate Tablets in Healthy Male Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 2, p. 207, doi. 10.1002/cpdd.841
- By:
- Publication type:
- Article
The Effects of Moxifloxacin on QTc Interval in Healthy Korean Male Subjects.
- Published in:
- Drugs in R&D, 2014, v. 14, n. 2, p. 63, doi. 10.1007/s40268-014-0040-1
- By:
- Publication type:
- Article
Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 5, p. 629, doi. 10.3390/pharmaceutics13050629
- By:
- Publication type:
- Article
A Population Pharmacokinetic Study to Compare a Novel Empagliflozin L-Proline Formulation with Its Conventional Formulation in Healthy Subjects.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 4, p. 522, doi. 10.3390/ph17040522
- By:
- Publication type:
- Article
Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 1, p. 132, doi. 10.3390/ph16010132
- By:
- Publication type:
- Article
Safety, Tolerability, and Serum/Tear Pharmacokinetics of Human Recombinant Epidermal Growth Factor Eyedrops in Healthy Subjects.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 11, p. 1312, doi. 10.3390/ph15111312
- By:
- Publication type:
- Article
The HLA- A*2402/ Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean population.
- Published in:
- Epilepsia (Series 4), 2015, v. 56, n. 10, p. e161, doi. 10.1111/epi.13087
- By:
- Publication type:
- Article
Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
- Published in:
- Epilepsia (Series 4), 2012, v. 53, n. 1, p. e9, doi. 10.1111/j.1528-1167.2011.03318.x
- By:
- Publication type:
- Article
A Personalized CYP2C19 Phenotype-Guided Dosing Regimen of Voriconazole Using a Population Pharmacokinetic Analysis.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 2, p. 227, doi. 10.3390/jcm8020227
- By:
- Publication type:
- Article
Evaluation of Food Effect on the Pharmacokinetics of Velufenacin, a New Muscarinic Receptor Antagonist, in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 2, p. 128, doi. 10.1002/cpdd.1361
- By:
- Publication type:
- Article
Pharmacokinetic Comparison Between a Fixed‐Dose Combination of Empagliflozin L‐Proline/Metformin and Empagliflozin/Metformin in Healthy Korean Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 12, p. 1156, doi. 10.1002/cpdd.1310
- By:
- Publication type:
- Article
Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in healthy subjects.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 7, p. 763, doi. 10.1111/apt.17406
- By:
- Publication type:
- Article
Featured Cover.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 7, p. i, doi. 10.1111/apt.16796
- By:
- Publication type:
- Article
Pharmacodynamics and pharmacokinetics of DWP14012 (fexuprazan) in healthy subjects with different ethnicities.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1648, doi. 10.1111/apt.16131
- By:
- Publication type:
- Article
Pharmacodynamics of tegoprazan and revaprazan after single and multiple oral doses in healthy subjects.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1640, doi. 10.1111/apt.16121
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Modeling of Fimasartan, Amlodipine, and Hydrochlorothiazide for the Investigation of Drug-Drug Interaction Potentials.
- Published in:
- Pharmaceutical Research, 2018, v. 35, n. 12, p. 1, doi. 10.1007/s11095-018-2511-5
- By:
- Publication type:
- Article
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 1, p. 80, doi. 10.1007/s10637-023-01405-z
- By:
- Publication type:
- Article
Development of a Korean‐specific virtual population for physiologically based pharmacokinetic modelling and simulation.
- Published in:
- Biopharmaceutics & Drug Disposition, 2019, v. 40, n. 3/4, p. 135, doi. 10.1002/bdd.2178
- By:
- Publication type:
- Article
Current Bioequivalence Study Designs in South Korea: A Comprehensive Analysis of Bioequivalence Study Reports Between 2013 and 2019.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.651790
- By:
- Publication type:
- Article
Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase-4 inhibitor, evogliptin ( DA-1229).
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 2, p. 294, doi. 10.1111/dom.12813
- By:
- Publication type:
- Article
Distribution of Exogenous and Endogenous CYP3A Markers and Related Factors in Healthy Males and Females.
- Published in:
- AAPS Journal, 2017, v. 19, n. 4, p. 1196, doi. 10.1208/s12248-017-0090-8
- By:
- Publication type:
- Article
Urinary 6β-Hydroxycortisol/Cortisol Ratio Most Highly Correlates With Midazolam Clearance Under Hepatic CYP3A Inhibition and Induction in Females: A Pharmacometabolomics Approach.
- Published in:
- AAPS Journal, 2016, v. 18, n. 5, p. 1254, doi. 10.1208/s12248-016-9941-y
- By:
- Publication type:
- Article
Investigating the Different Mechanisms of Genotoxic and Non-Genotoxic Carcinogens by a Gene Set Analysis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086700
- By:
- Publication type:
- Article
Compartmental modeling and simplified quantification of [C]sertraline distribution in human brain.
- Published in:
- Archives of Pharmacal Research, 2012, v. 35, n. 9, p. 1591, doi. 10.1007/s12272-012-0910-4
- By:
- Publication type:
- Article
Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 78, n. 4, p. 342, doi. 10.1016/j.clpt.2005.07.003
- By:
- Publication type:
- Article
Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 6, p. 486, doi. 10.1016/j.clpt.2005.02.006
- By:
- Publication type:
- Article
Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 2, p. 104, doi. 10.1016/j.clpt.2004.03.009
- By:
- Publication type:
- Article
A variant 2677A allele of the MDR1 gene affects fexofenadine disposition<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 5, p. 418, doi. 10.1016/j.clpt.2004.08.002
- By:
- Publication type:
- Article
Ethnic differences and relationships in the oral pharmacokinetics of nifedipine and erythromycin<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 3, p. 228, doi. 10.1067/mcp.2001.117703
- By:
- Publication type:
- Article
Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 69, n. 4, p. 266, doi. 10.1067/mcp.2001.114231
- By:
- Publication type:
- Article
Pharmacokinetics of Lacosamide in Healthy Korean Male Volunteers.
- Published in:
- Pharmacology, 2012, v. 89, n. 3/4, p. 172, doi. 10.1159/000336774
- By:
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics and safety of oral formulation (CG‐750) of ivaltinostat, a histone deacetylase inhibitor, compared to IV formulation (CG‐745).
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 4, p. 1103, doi. 10.1111/bcp.15997
- By:
- Publication type:
- Article
Dose‐dependent glucosuria of DWP16001, a novel selective sodium–glucose cotransporter‐2 inhibitor, in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 9, p. 4100, doi. 10.1111/bcp.15348
- By:
- Publication type:
- Article
Night‐time gastric acid suppression by tegoprazan compared to vonoprazan or esomeprazole.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 7, p. 3288, doi. 10.1111/bcp.15268
- By:
- Publication type:
- Article
Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 138, doi. 10.1111/bcp.14934
- By:
- Publication type:
- Article
Pharmacokinetics of human antithrombin III concentrate in the immediate postoperative period after liver transplantation.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 5, p. 923, doi. 10.1111/bcp.14200
- By:
- Publication type:
- Article
Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 6, p. 1279, doi. 10.1111/bcp.13211
- By:
- Publication type:
- Article
Pharmacokinetics and safety of a single dose of the novel necrosis inhibitor LC28-0126 in healthy male subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 6, p. 1205, doi. 10.1111/bcp.13213
- By:
- Publication type:
- Article
Effects of HM30181, a P-glycoprotein inhibitor, on the pharmacokinetics and pharmacodynamics of loperamide in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 78, n. 3, p. 556, doi. 10.1111/bcp.12368
- By:
- Publication type:
- Article
Apple juice greatly reduces systemic exposure to atenolol.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 1, p. 172, doi. 10.1111/j.1365-2125.2012.04324.x
- By:
- Publication type:
- Article
Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from Cirrhosis.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1497, doi. 10.3390/cancers11101497
- By:
- Publication type:
- Article
Pharmacokinetics and tolerability of eletriptan hydrobromide in healthy Korean subjects.
- Published in:
- International Journal of Nanomedicine, 2018, v. 13, p. 331, doi. 10.2147/DDDT.S149119
- By:
- Publication type:
- Article
Ursodeoxycholic acid exerts hepatoprotective effects by regulating amino acid, flavonoid, and fatty acid metabolic pathways.
- Published in:
- Metabolomics, 2019, v. 15, n. 3, p. N.PAG, doi. 10.1007/s11306-019-1494-5
- By:
- Publication type:
- Article
Calculating occupancy when one does not have baseline: a comparison of different options.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2011, v. 31, n. 8, p. 1760, doi. 10.1038/jcbfm.2011.54
- By:
- Publication type:
- Article